Dergiler / Journal of Health Sciences and Medicine / 2026 / Volume: 9 Issue: 5

MRI features of colorectal liver metastases before and after chemotherapy using gadoxetic acid: a single-center retrospective study

Duygu Karahacıoğlu(KOC UNIVERSITY, SCHOOL OF MEDICINE)0000-0003-1365-871X
Hande Özen Atalay(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL FATİH SULTAN MEHMET TRAINING RESEARCH CENTER)0000-0003-3524-9597
Sayfa
—
Yayın Tarihi
2026-09-19
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Awareness of post-treatment imaging changes is essential for accurate response assessment.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: To evaluate the frequency of typical magnetic resonance imaging (MRI) signal characteristics of colorectal liver metastases (CRLM) before and after chemotherapy using gadoxetic acid-enhanced MRI.
📊
Temel Bulgular & Veri:Methods: Forty-four patients (29 male, 15 female; median age 61 years, IQR 52-69) who underwent gadoxetic acid-enhanced MRI for CRLM between January 2020 and November 2022 were retrospectively evaluated.
💡
Sonuç & Katkı:Awareness of post-treatment imaging changes is essential for accurate response assessment.
🔬Tür:Research Article
📍Kapsam:2020 Verileri
⚙️Değişkenler:Colorectal liver metastases · gadoxetic acid · MRI

Abstract

Aims: To evaluate the frequency of typical magnetic resonance imaging (MRI) signal characteristics of colorectal liver metastases (CRLM) before and after chemotherapy using gadoxetic acid-enhanced MRI. Methods: Forty-four patients (29 male, 15 female; median age 61 years, IQR 52-69) who underwent gadoxetic acid-enhanced MRI for CRLM between January 2020 and November 2022 were retrospectively evaluated. Mucinous/cystic lesions and poor-quality examinations were excluded. A maximum of 5 lesions per patient were assessed (75 pre-chemotherapy, 125 post-chemotherapy; 200 total). T2-weighted (T2W), diffusion-weighted (DWI), contrast-enhanced T1-weighted (CE-T1W), and hepatobiliary phase (HBP) image features were recorded. Chi-square, Fisher exact, and McNemar tests were used. Results: Pre-chemotherapy, moderate T2W hyperintensity was present in 93.3%, diffusion restriction in 81.3%, ring enhancement in 56.0%, and HBP hypointensity in 100% of lesions. Post-chemotherapy, these rates changed to 68.8% (p=0.0002), 37.6% (p<0.001), 35.2% (p=0.016), and 96.8% (p=0.299), respectively. Peripheral HBP hyperintensity increased from 1.3% to 10.4% (p=0.019). Paired McNemar analysis (n=17 patients) confirmed significant reductions in DWI restriction (80.4% vs. 42.9%, p<0.001), moderate T2W hyperintensity (98.2% vs. 69.6%, p<0.001), ring enhancement (55.4% vs. 25.0%, p=0.001), and targetoid appearance (46.4% vs. 26.8%, p=0.027). Conclusion: Typical gadoxetic acid-enhanced MRI features of CRLM decrease significantly after chemotherapy. HBP hypointensity is largely preserved and remains the most reliable feature for lesion detection. Awareness of post-treatment imaging changes is essential for accurate response assessment.

🔖

Bu Makaleye Atıf Yap

Karahacıoğlu, D., Atalay, H. Ö. (2026). MRI features of colorectal liver metastases before and after chemotherapy using gadoxetic acid: a single-center retrospective study. Journal of Health Sciences and Medicine, Volume: 9 Issue: 5. https://doi.org/10.32322/jhsm.1936248

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Ozaki K, Higuchi S, Kimura H, Gabata T. Liver metastases: correlation between imaging features and pathomolecular environments. RadioGraphics. 2022;42(7):1994-2013. doi:10.1148/rg.220056
  2. Renzulli M, Clemente A, Ierardi AM, et al. Imaging of colorectal liver metastases: new developments and pending issues. Cancers. 2020;12(1): 151. doi:10.3390/cancers12010151
  3. Sibinga Mulder BG, Visser K, Feshtali S, et al. Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases. BMC Med Imaging. 2018; 18(1):44. doi:10.1186/s12880-018-0289-x
  4. Beckers RCJ, Lambregts DMJ, Lahaye MJ, et al. Advanced imaging to predict response to chemotherapy in colorectal liver metastases: a systematic review. HPB (Oxford). 2018;20(2):120-127. doi:10.1016/j.hpb. 2017.10.013
  5. Maclean D, Tsakok M, Gleeson F, et al. Comprehensive imaging characterization of colorectal liver metastases. Front Oncol. 2021;11: 730854. doi:10.3389/fonc.2021.730854
  6. Granata V, Catalano O, Fusco R, et al. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA uptake on the hepatobiliary phase of MR imaging. Abdom Imaging. 2015;40(7):2364-2371. doi:10.1007/s00261-015-0488-7
  7. van Kessel CS, Buckens CFM, van den Bosch MAAJ, et al. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol. 2012;19(9):2805-2813. doi:10.1245/s10434-012-2300-z
  8. Nakai Y, Gonoi W, Kurokawa R, et al. MRI findings of liver parenchyma peripheral to colorectal liver metastasis: a potential predictor of long-term prognosis. Radiology. 2020;297(3):584–594. doi:10.1148/radiol.2020202367
  9. Kadiyoran C, Cizmecioglu HA, Cure E, Yildirim MA, Yilmaz PD. Liver metastasis in colorectal cancer: evaluation of segmental distribution. Prz Gastroenterol. 2019;14(3):188-192. doi:10.5114/pg.2019.88168